Myelin Basic Protein Antibodies

Santa Cruz Biotechnology features a diverse variety of Myelin Basic Protein Antibodies for neurobiology and related fields research. Myelin Basic Protein Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Myelin Basic Protein (MBP) plays a crucial role in the formation and maintenance of myelin sheaths, which insulate nerve fibers and facilitate efficient signal transmission in the nervous system. Abnormalities in MBP expression or function are associated with demyelinating diseases such as multiple sclerosis, making it a significant target for research aimed at understanding and treating neurological conditions. The study of Myelin Basic Protein is essential for elucidating the mechanisms underlying myelination and its impact on neurological health. Understanding MBP function can provide valuable insights into the development of therapeutic strategies for treating demyelinating disorders. Research focusing on MBP has revealed important aspects of myelin structure and function in both healthy and diseased states. Investigating MBP interactions with other proteins helps illuminate complex neural pathways and signaling mechanisms. Santa Cruz Biotechnology monoclonal antibodies for Myelin Basic Protein enable researchers to advance scientific understanding of myelin-related disorders and contribute to potential therapeutic developments.